← Insider buys
CRNX

Crinetics Pharmaceuticals, Inc. · Healthcare

COO Jeff E. Knight sold $42K of Crinetics Pharmaceuticals, Inc.

Sold$42,427
$44.38Price
956Shares
−2%Stake

What CRNX did after the filing

Filed Jun 28Copier in Jul 1
The stock from Mon, Jul 1 open, $44.90
+12.1%
S&P 500, same days
−0.7%

Measured over 30 trading days, to the Aug 13 close.

Traded Wed, Jun 26. Filed Fri, Jun 28, 5:31 PM ET, after the close. Returns use the Jul 1 open and the Aug 13 close. Not investment advice.